Are you Dr. Paterson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 13 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
119 Belmont St
Department of General Surgery
Worcester, MA 01605Phone+1 508-334-8195Fax+1 508-334-5374- Is this information wrong?
Summary
- Dr. Craig Paterson, MD is a general surgeon in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Colon and Rectal Surgery, 1997 - 1998
Michael G. DeGroote School of MedicineClass of 1992
Certifications & Licensure
MA State Medical License 2001 - 2016
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters. Start of enrollment: 2008 Nov 01
Publications & Presentations
PubMed
- 4 citationsImmune Responses Associated With Perioperative Exposure and Reexposure to Topical Bovine Thrombin Do Not Impair HemostasisCraig Paterson, Glenn C. Pixton, Howard M. Proskin, Joseph M. Massaro, Mark D. Morasch, Bruce N. Cronstein, Jawed Fareed, Frederick A. Ofosu> ;Clinical and Applied Thrombosis/hemostasis. 2011 May 18
- 1 citationsA Multicenter Pilot Study to Estimate the Prevalence of Bovine and Human Coagulation Antibodies in the General US PopulationJawed Fareed, Craig Paterson, Sheila M. Crean> ;Clinical and Applied Thrombosis/hemostasis. 2011 Apr 1
- 6 citationsEffectiveness and safety of diclofenac epolamine topical patch 1.3% for the treatment of acute pain due to back strain: an open-label, uncontrolled study.Joseph Gimbel, David Jacobs, Glenn C. Pixton, Craig Paterson> ;The Physician and Sportsmedicine. 2011 Feb 1
- Join now to see all
Press Mentions
Allakos (ALLK) Reports Complete Patient Enrollment in Phase 3 EG/EoD and Phase 2/3 EoE Clinical Trials of Lirentelimab (AK002)June 7th, 2021- Has Covid-19 Made Life Insurance Less Accessible?August 25th, 2020
Professional Memberships
- Member
